"Nano-electronic" sequencer whose goal is to achieve 1kb reads by reading changes in both pH and temperature: http://venturebeat.com/2013/11/14/yu...into-genapsys/
- Genohub
- Genohub
-
-
Any specifics on the technology?
Illumina has a 12 billion market cap and a significant lead. -
Not many specifics:
"The "Gene Electronic Nano-Integrated Ultra-Sensitive" (GENIUS) platform is based on innovative technologies to provide significant improvements in cost, accuracy, read length, throughput and ease of use relative to current state-of-art systems. The overall goal is to develop a sequencing system using nano-magnetic-electronic platforms. We are proposing a system that integrates sample preparation and enrichment steps with the sequencing module. Sample preparation will rely on a re-usable magnetic-electronic chip and a novel emulsion-free amplification method. After amplification, enrichment of template carrying monoclonal beads is achieved through 'sorting' based on DNA charge. Beads are then transferred and held on a micromagnet array integrated with a sequencing sensor chip consisting of high-density arrays of CMOS-based nano-electronic sensors for direct detection of extension reactions. "
Here are a couple links to their NIH grants:
LOW COST SEQUENCING WITH RE-USABLE MAGNETIC ARRAYS AND NANOELECTRONIC SENSORS
FABRICATION OF A DUAL NANO-BIOSENSOR FOR ACCURATE SENSITIVE AND INEXPENSIVE ELEC
- GenohubComment
-
We've been keeping track of them over in our 'Emerging Technologies' section of the NGS Knowledge Bank: http://allseq.com/knowledgebank/emer...gies/genapsys/Originally posted by Richard Finney View PostComment
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment